Clinical Study
Quantifying the Increase in Radiation Exposure Associated with SPECT/CT Compared to SPECT Alone for Routine Nuclear Medicine Examinations
Table 5
Effective dose and equivalent background radiation for the total SPECT/CT effective dose for each examination.
| | Study type | Total effective dose (mSv) | Equivalent background radiation (years) |
| | 67Gallium | 45.2 | 15.1 | | 99mTc-MDP | 10.1 | 3.4 | | 99mTc-MIBI parathyroid | 13.7 | 4.6 | | 111In-Octreotide | 19.0 | 6.3 | | 111In-WBC | 13.1 | 4.4 | |
Tc99m Ceretec | 22.0 | 7.3 | | 131I Uptake | 44.1 | 14.7 | | 131I Posttherapy Scan | 2892.8 | 964.3 | | 111In Chloride (ProstaScint) | 41.9 | 14.0 |
|
|
